Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFPT1 | Q06210 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | GGT1 | P19440 | 4/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29560900 | 1.00 | GFPT1 (0.47) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| SCHEMBL1973452 | 1.00 | GFPT1 (0.47) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| SCHEMBL10280376 | 0.82 | GFPT1 (0.49) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| SCHEMBL31524073 | 0.80 | CYP2D6 (0.50) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| SCHEMBL12648290 | 0.79 | GFPT1 (0.54) | GFPT1GRIK1GRIK2SLC7A5SLC1A3 | |
| SCHEMBL10187391 | 0.79 | GFPT1 (0.46) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| Albizziine SCHEMBL1006298 | 0.78 | GFPT1 (0.48) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| Albizziine SCHEMBL9361011 | 0.78 | GFPT1 (0.48) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| Albizziine SCHEMBL690347 | 0.78 | GFPT1 (0.48) | GFPT1PTGS1SLC7A11GGT1GRIK1 | |
| Albizziine SCHEMBL1006299 | 0.78 | GFPT1 (0.48) | GFPT1PTGS1SLC7A11GGT1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 459 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724570-A1 | SMALL MOLECULE BASED METHOD OF MODIFYING T CELLS | Agency for Science, Technology and Research (SG) | 2026-04-15 | — | — | EP | claimed |
| US-20250129170-A1 | EPO RECEPTOR AGONISTS AND ANTAGONISTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-04-24 | — | — | US | claimed |
| CN-119498513-A | Post-ripe red ginseng tablet and preparation method thereof | 广东贞观生物科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119365486-A | EPO receptor agonists and antagonists | 免疫先锋股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| EP-4490187-A2 | EPO RECEPTOR AGONISTS AND ANTAGONISTS | Immunedge, Inc. (US) | 2025-01-15 | — | — | EP | claimed |
| WO-2024253594-A1 | SMALL MOLECULE BASED METHOD OF MODIFYING T CELLS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2024-12-12 | — | — | WO | claimed |
| CN-118987005-A | Notoginseng radix component composition for treating qi stagnation and blood stasis syndrome | 漳州片仔癀药业股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118846204-A | Traditional Chinese medicine liquid band-aid and preparation method thereof | 贵州中医药大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118217207-B | Hemostatic and anti-inflammatory toothpaste and preparation method and application thereof | 广州舒客实业有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118632697-A | Bioactive compositions and methods of use thereof | 南京纽邦生物科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-112121223-B | Sericin medical dressing and production method thereof | 河南民兴生物科技股份有限公司 | 2022-05-20 | — | — | CN | claimed |
| CN-114469918-A | Application of dencichine in preparing non-alcoholic fatty liver disease prevention and treatment medicine | 南通大学 | 2022-05-13 | — | — | CN | claimed |
| CN-114432494-A | Sanchinin-loaded hydrogel and preparation method thereof | 宁波市第一医院 | 2022-05-06 | — | — | CN | claimed |
| CN-114366844-A | Gelatin-chitosan-dencichine composite hemostatic membrane material and preparation method thereof | 成都汉丁新材料科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-114344942-A | Pretreatment method for extracting dencichine from plants | 天水师范学院 | 2022-04-15 | — | — | CN | claimed |
| CN-114315629-A | Method for separating and purifying dencichine from leguminous plants | 天水师范学院 | 2022-04-12 | — | — | CN | claimed |
| CN-113952355-A | Traditional Chinese medicine nano-composite for hemostasis and anti-inflammation and preparation method thereof | 纪舒馨 | 2022-01-21 | — | — | CN | claimed |
| CN-113274506-A | Drug delivery technology of polymer-carbohydrate conjugates | 念·吴 | 2021-08-20 | — | — | CN | claimed |
| CN-108822469-A | A kind of environmental-friendly halogen-free low-smoke high fire-retardance protective cover material | 江苏东方电缆材料有限公司 | 2018-11-16 | — | — | CN | claimed |
| EP-0516132-A1 | Anti-neuronotoxic activity and therapeutic applications of GM1 ganglioside methyl ester | FIDIA S.p.A. (IT) | 1992-12-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129170-A1 | EPO RECEPTOR AGONISTS AND ANTAGONISTS | EPOR, MPL, PRLHR | GFPT1 3816/4885PTGS1 1272/4885SLC7A11 4045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.